Kevin Ess
Concepts (328)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 22 | 2025 | 49 | 4.940 |
Why?
| Tumor Suppressor Proteins | 13 | 2023 | 311 | 3.280 |
Why?
| Induced Pluripotent Stem Cells | 14 | 2025 | 221 | 1.680 |
Why?
| TOR Serine-Threonine Kinases | 10 | 2023 | 398 | 1.550 |
Why?
| Sirolimus | 7 | 2024 | 270 | 1.070 |
Why?
| Astrocytoma | 3 | 2021 | 115 | 1.050 |
Why?
| Sodium-Potassium-Exchanging ATPase | 3 | 2025 | 51 | 1.040 |
Why?
| Neural Stem Cells | 7 | 2019 | 142 | 1.000 |
Why?
| Tumor Suppressor Protein p53 | 5 | 2017 | 503 | 0.990 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 9 | 2025 | 118 | 0.950 |
Why?
| Multiprotein Complexes | 4 | 2013 | 154 | 0.920 |
Why?
| Neurons | 8 | 2020 | 1509 | 0.910 |
Why?
| Hemiplegia | 3 | 2025 | 21 | 0.880 |
Why?
| Brain | 9 | 2024 | 2677 | 0.870 |
Why?
| Epilepsy | 5 | 2021 | 322 | 0.840 |
Why?
| Signal Transduction | 14 | 2023 | 4935 | 0.820 |
Why?
| Zebrafish | 6 | 2023 | 460 | 0.780 |
Why?
| Cell Differentiation | 10 | 2025 | 1900 | 0.750 |
Why?
| Epilepsy, Generalized | 1 | 2021 | 17 | 0.730 |
Why?
| Mosaicism | 1 | 2021 | 69 | 0.700 |
Why?
| White Matter | 4 | 2017 | 135 | 0.680 |
Why?
| Loss of Heterozygosity | 1 | 2017 | 45 | 0.570 |
Why?
| Neurogenesis | 3 | 2017 | 126 | 0.550 |
Why?
| Cellular Reprogramming | 1 | 2017 | 95 | 0.540 |
Why?
| Autistic Disorder | 1 | 2019 | 189 | 0.530 |
Why?
| Brain Neoplasms | 2 | 2021 | 1149 | 0.520 |
Why?
| Heterozygote | 2 | 2017 | 271 | 0.520 |
Why?
| Autism Spectrum Disorder | 1 | 2021 | 386 | 0.500 |
Why?
| Diffusion Tensor Imaging | 2 | 2015 | 76 | 0.480 |
Why?
| Everolimus | 4 | 2025 | 88 | 0.450 |
Why?
| Gene Deletion | 2 | 2013 | 380 | 0.440 |
Why?
| Mutation | 9 | 2025 | 3706 | 0.440 |
Why?
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2013 | 2 | 0.420 |
Why?
| Electron-Transferring Flavoproteins | 1 | 2013 | 4 | 0.420 |
Why?
| Zebrafish Proteins | 2 | 2013 | 268 | 0.420 |
Why?
| Carrier Proteins | 4 | 2015 | 741 | 0.410 |
Why?
| Mice, Knockout | 12 | 2019 | 2888 | 0.410 |
Why?
| Gene Knock-In Techniques | 1 | 2013 | 53 | 0.410 |
Why?
| Astrocytes | 5 | 2024 | 197 | 0.400 |
Why?
| Regenerative Medicine | 1 | 2013 | 46 | 0.400 |
Why?
| Kidney Tubules, Distal | 1 | 2012 | 4 | 0.390 |
Why?
| Mitochondrial Diseases | 1 | 2013 | 90 | 0.390 |
Why?
| Disease Models, Animal | 13 | 2017 | 4077 | 0.390 |
Why?
| Neuroglia | 2 | 2011 | 167 | 0.390 |
Why?
| Gene Silencing | 1 | 2013 | 190 | 0.380 |
Why?
| Seizures | 4 | 2021 | 402 | 0.380 |
Why?
| Animals | 34 | 2025 | 35409 | 0.380 |
Why?
| Nerve Fibers, Myelinated | 1 | 2012 | 45 | 0.380 |
Why?
| Immunosuppressive Agents | 2 | 2019 | 858 | 0.380 |
Why?
| Stem Cell Transplantation | 1 | 2013 | 166 | 0.370 |
Why?
| Rapamycin-Insensitive Companion of mTOR Protein | 4 | 2017 | 28 | 0.370 |
Why?
| Corpus Callosum | 1 | 2012 | 65 | 0.370 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 443 | 0.350 |
Why?
| Myelin Sheath | 3 | 2017 | 160 | 0.350 |
Why?
| Blood-Brain Barrier | 2 | 2024 | 132 | 0.350 |
Why?
| Mice | 23 | 2025 | 16983 | 0.350 |
Why?
| Cell Transformation, Neoplastic | 1 | 2013 | 319 | 0.350 |
Why?
| Cilia | 1 | 2012 | 180 | 0.350 |
Why?
| Interneurons | 1 | 2011 | 120 | 0.340 |
Why?
| Codon, Nonsense | 1 | 2010 | 40 | 0.340 |
Why?
| Nervous System Diseases | 1 | 2013 | 252 | 0.330 |
Why?
| Trans-Activators | 4 | 2012 | 392 | 0.320 |
Why?
| Cerebral Cortex | 4 | 2020 | 439 | 0.310 |
Why?
| Humans | 46 | 2025 | 129847 | 0.310 |
Why?
| Mutant Proteins | 2 | 2023 | 100 | 0.290 |
Why?
| Alleles | 3 | 2017 | 843 | 0.280 |
Why?
| Neurobiology | 1 | 2006 | 15 | 0.250 |
Why?
| Child | 12 | 2025 | 20962 | 0.240 |
Why?
| Carcinogenesis | 2 | 2019 | 214 | 0.240 |
Why?
| Electroencephalography | 2 | 2021 | 409 | 0.230 |
Why?
| Mechanistic Target of Rapamycin Complex 2 | 3 | 2017 | 62 | 0.230 |
Why?
| Huntington Disease | 2 | 2016 | 49 | 0.230 |
Why?
| Proto-Oncogene Proteins | 3 | 1999 | 634 | 0.220 |
Why?
| Cell Culture Techniques | 2 | 2019 | 349 | 0.220 |
Why?
| Cells, Cultured | 7 | 2020 | 4102 | 0.220 |
Why?
| Proteins | 4 | 2015 | 944 | 0.210 |
Why?
| Transcription Factors | 4 | 2012 | 1645 | 0.200 |
Why?
| Arrhythmias, Cardiac | 1 | 2025 | 322 | 0.200 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2014 | 157 | 0.190 |
Why?
| Fatty Acids | 1 | 2025 | 427 | 0.190 |
Why?
| Embryonic and Fetal Development | 2 | 1999 | 95 | 0.180 |
Why?
| Oncogenes | 2 | 1999 | 110 | 0.180 |
Why?
| Thymus Gland | 3 | 1999 | 309 | 0.180 |
Why?
| Mitochondria | 4 | 2015 | 875 | 0.180 |
Why?
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 2 | 0.180 |
Why?
| Gene Expression Profiling | 2 | 2005 | 1686 | 0.170 |
Why?
| Endothelial Cells | 3 | 2025 | 749 | 0.170 |
Why?
| GTPase-Activating Proteins | 1 | 2020 | 81 | 0.170 |
Why?
| DNA Methylation | 1 | 2025 | 606 | 0.160 |
Why?
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 15 | 0.160 |
Why?
| Cardiomyopathy, Dilated | 1 | 2023 | 381 | 0.160 |
Why?
| Female | 16 | 2025 | 68829 | 0.160 |
Why?
| Gene Expression Regulation, Developmental | 5 | 2017 | 820 | 0.160 |
Why?
| Immunization | 1 | 2021 | 411 | 0.150 |
Why?
| Drug Resistant Epilepsy | 1 | 2020 | 81 | 0.150 |
Why?
| Lateral Ventricles | 1 | 2019 | 36 | 0.150 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 68 | 0.150 |
Why?
| Aquaporin 4 | 1 | 2019 | 95 | 0.150 |
Why?
| Male | 14 | 2025 | 63759 | 0.150 |
Why?
| Mutation, Missense | 1 | 2020 | 316 | 0.150 |
Why?
| Wnt Signaling Pathway | 2 | 2023 | 170 | 0.150 |
Why?
| Recurrence | 1 | 2021 | 1013 | 0.150 |
Why?
| Parkinson Disease | 2 | 2014 | 462 | 0.140 |
Why?
| Manganese | 2 | 2014 | 59 | 0.140 |
Why?
| Genes, p53 | 1 | 2017 | 70 | 0.140 |
Why?
| Membrane Potentials | 1 | 2018 | 292 | 0.140 |
Why?
| Fibrosis | 1 | 2019 | 526 | 0.130 |
Why?
| Practice Guidelines as Topic | 2 | 2021 | 1514 | 0.130 |
Why?
| Phenotype | 3 | 2020 | 3062 | 0.130 |
Why?
| Child, Preschool | 7 | 2025 | 10522 | 0.130 |
Why?
| Demyelinating Diseases | 1 | 2016 | 84 | 0.130 |
Why?
| Myocytes, Cardiac | 2 | 2023 | 499 | 0.130 |
Why?
| Genomic Instability | 1 | 2016 | 48 | 0.120 |
Why?
| Central Nervous System | 1 | 2017 | 256 | 0.120 |
Why?
| Infant | 6 | 2018 | 9018 | 0.120 |
Why?
| RNA, Small Interfering | 1 | 2017 | 590 | 0.120 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 317 | 0.120 |
Why?
| Polyesters | 1 | 2015 | 75 | 0.120 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 65 | 0.110 |
Why?
| Cell Line | 6 | 2015 | 2780 | 0.110 |
Why?
| Chromatin | 2 | 2015 | 478 | 0.110 |
Why?
| Flow Cytometry | 2 | 2024 | 1160 | 0.110 |
Why?
| Neuroimaging | 1 | 2016 | 279 | 0.110 |
Why?
| Cadmium | 1 | 2014 | 67 | 0.110 |
Why?
| Magnetic Resonance Imaging | 2 | 2016 | 3397 | 0.110 |
Why?
| Enhancer Elements, Genetic | 1 | 1995 | 177 | 0.110 |
Why?
| RNA, Messenger | 3 | 2020 | 2703 | 0.110 |
Why?
| Protein Structure, Tertiary | 2 | 2015 | 844 | 0.110 |
Why?
| Copper | 1 | 2014 | 108 | 0.110 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 129 | 0.110 |
Why?
| Checklist | 1 | 2014 | 94 | 0.110 |
Why?
| Glutamic Acid | 2 | 2007 | 235 | 0.110 |
Why?
| Brain Diseases | 1 | 2014 | 134 | 0.100 |
Why?
| Founder Effect | 1 | 2013 | 11 | 0.100 |
Why?
| Pluripotent Stem Cells | 1 | 2014 | 77 | 0.100 |
Why?
| Corpus Striatum | 1 | 2014 | 154 | 0.100 |
Why?
| Abdominal Neoplasms | 1 | 2013 | 34 | 0.100 |
Why?
| Models, Theoretical | 1 | 2016 | 549 | 0.100 |
Why?
| Manganese Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
| Parkinson Disease, Secondary | 1 | 2012 | 7 | 0.100 |
Why?
| Stem Cells | 3 | 2023 | 578 | 0.100 |
Why?
| Adolescent | 7 | 2025 | 20451 | 0.100 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 51 | 0.100 |
Why?
| Homozygote | 1 | 2013 | 195 | 0.100 |
Why?
| Fibroblasts | 1 | 2017 | 954 | 0.100 |
Why?
| Genetic Testing | 1 | 2015 | 422 | 0.100 |
Why?
| Paired Box Transcription Factors | 1 | 2012 | 40 | 0.100 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 260 | 0.090 |
Why?
| Fluorescent Antibody Technique | 1 | 2012 | 377 | 0.090 |
Why?
| Chlorides | 1 | 2012 | 139 | 0.090 |
Why?
| Exons | 1 | 2013 | 341 | 0.090 |
Why?
| Ribosomes | 1 | 2013 | 165 | 0.090 |
Why?
| Blotting, Western | 2 | 2012 | 1204 | 0.090 |
Why?
| Eye Proteins | 1 | 2012 | 88 | 0.090 |
Why?
| SOXB1 Transcription Factors | 1 | 2012 | 57 | 0.090 |
Why?
| Cognition | 1 | 2019 | 1125 | 0.090 |
Why?
| Blood Vessels | 1 | 2013 | 187 | 0.090 |
Why?
| Bone Morphogenetic Proteins | 1 | 2012 | 129 | 0.090 |
Why?
| Mice, Transgenic | 2 | 2013 | 2135 | 0.090 |
Why?
| Neovascularization, Pathologic | 1 | 2013 | 297 | 0.090 |
Why?
| Gene-Environment Interaction | 1 | 2012 | 185 | 0.090 |
Why?
| Quinolines | 1 | 2012 | 156 | 0.090 |
Why?
| Lung | 1 | 2023 | 3940 | 0.090 |
Why?
| Cell Lineage | 2 | 2019 | 332 | 0.090 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 434 | 0.090 |
Why?
| Cell Size | 1 | 2010 | 89 | 0.090 |
Why?
| Environmental Pollutants | 1 | 2012 | 143 | 0.090 |
Why?
| Liver | 3 | 2015 | 1839 | 0.090 |
Why?
| gamma-Aminobutyric Acid | 1 | 2011 | 168 | 0.090 |
Why?
| Autophagy | 1 | 2013 | 266 | 0.090 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2013 | 528 | 0.080 |
Why?
| Polyethylene Glycols | 1 | 2015 | 612 | 0.080 |
Why?
| Molecular Targeted Therapy | 1 | 2013 | 391 | 0.080 |
Why?
| Cell Proliferation | 1 | 2017 | 2378 | 0.080 |
Why?
| Embryo, Nonmammalian | 1 | 2010 | 167 | 0.080 |
Why?
| Up-Regulation | 1 | 2013 | 836 | 0.080 |
Why?
| Biomedical Research | 1 | 2016 | 640 | 0.080 |
Why?
| Cell Death | 1 | 2011 | 353 | 0.080 |
Why?
| Spinal Cord Injuries | 1 | 2013 | 194 | 0.080 |
Why?
| Hepatocytes | 1 | 2010 | 215 | 0.080 |
Why?
| Proto-Oncogene Proteins c-myb | 3 | 1999 | 10 | 0.080 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2545 | 0.080 |
Why?
| Cell Cycle Proteins | 1 | 2013 | 583 | 0.080 |
Why?
| Behavior, Animal | 1 | 2012 | 496 | 0.080 |
Why?
| Repressor Proteins | 1 | 2012 | 404 | 0.080 |
Why?
| Pyrazoles | 1 | 2012 | 403 | 0.070 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 1033 | 0.070 |
Why?
| Aging | 2 | 2023 | 1774 | 0.070 |
Why?
| Kidney Diseases | 1 | 2012 | 382 | 0.070 |
Why?
| Homeodomain Proteins | 1 | 2012 | 493 | 0.070 |
Why?
| Glial Fibrillary Acidic Protein | 2 | 2007 | 91 | 0.070 |
Why?
| Adult | 7 | 2021 | 35634 | 0.070 |
Why?
| Immunohistochemistry | 1 | 2011 | 1690 | 0.070 |
Why?
| Protein Biosynthesis | 2 | 2013 | 406 | 0.070 |
Why?
| Sleep | 1 | 2012 | 689 | 0.070 |
Why?
| DNA | 2 | 2012 | 1406 | 0.060 |
Why?
| Mental Disorders | 1 | 2014 | 1035 | 0.060 |
Why?
| Anxiety | 1 | 2012 | 976 | 0.060 |
Why?
| Regulatory-Associated Protein of mTOR | 1 | 2025 | 18 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 1005 | 0.060 |
Why?
| Synaptic Transmission | 1 | 2007 | 275 | 0.060 |
Why?
| Neuronal Plasticity | 1 | 2007 | 278 | 0.060 |
Why?
| Amino Acid Motifs | 2 | 2015 | 215 | 0.060 |
Why?
| Genetic Markers | 1 | 2005 | 334 | 0.050 |
Why?
| Death, Sudden, Cardiac | 1 | 2025 | 179 | 0.050 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2014 | 67 | 0.050 |
Why?
| Centrosome | 1 | 2023 | 64 | 0.050 |
Why?
| DNA Damage | 2 | 2016 | 383 | 0.050 |
Why?
| Hypertension, Pulmonary | 1 | 2014 | 1897 | 0.050 |
Why?
| Case-Control Studies | 2 | 2025 | 3384 | 0.050 |
Why?
| Neoplasm Metastasis | 1 | 2025 | 610 | 0.050 |
Why?
| Molecular Sequence Data | 3 | 2015 | 2833 | 0.050 |
Why?
| Phosphopyruvate Hydratase | 1 | 2002 | 26 | 0.050 |
Why?
| Binding Sites | 2 | 2015 | 1251 | 0.050 |
Why?
| Electrocardiography | 1 | 2025 | 613 | 0.050 |
Why?
| Genetic Predisposition to Disease | 3 | 2015 | 2271 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2005 | 569 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2025 | 627 | 0.040 |
Why?
| Vaccines, Synthetic | 1 | 2021 | 126 | 0.040 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 74 | 0.040 |
Why?
| Drug Approval | 1 | 2021 | 87 | 0.040 |
Why?
| Malformations of Cortical Development | 1 | 2020 | 13 | 0.040 |
Why?
| Haploinsufficiency | 1 | 2020 | 48 | 0.040 |
Why?
| Genetic Variation | 1 | 2025 | 937 | 0.040 |
Why?
| Patient Advocacy | 1 | 2020 | 73 | 0.040 |
Why?
| Advisory Committees | 1 | 2021 | 216 | 0.040 |
Why?
| Stroke Volume | 1 | 2023 | 593 | 0.040 |
Why?
| Seizures, Febrile | 1 | 2019 | 21 | 0.040 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2019 | 28 | 0.040 |
Why?
| Ventricular Function, Left | 1 | 2023 | 529 | 0.040 |
Why?
| Cell Survival | 2 | 2013 | 1086 | 0.040 |
Why?
| Machine Learning | 1 | 2024 | 441 | 0.040 |
Why?
| Thyroid Nuclear Factor 1 | 1 | 2019 | 15 | 0.040 |
Why?
| Odontogenesis | 1 | 1999 | 11 | 0.040 |
Why?
| Digestive System | 1 | 1999 | 29 | 0.040 |
Why?
| Adenosine Deaminase | 2 | 1996 | 29 | 0.040 |
Why?
| Culture Media | 1 | 2019 | 162 | 0.040 |
Why?
| Hair Follicle | 1 | 1999 | 45 | 0.040 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 125 | 0.040 |
Why?
| Models, Biological | 1 | 2006 | 1724 | 0.040 |
Why?
| Tamoxifen | 1 | 2019 | 197 | 0.040 |
Why?
| Thyroid Gland | 1 | 1999 | 95 | 0.040 |
Why?
| In Situ Hybridization | 1 | 1999 | 296 | 0.040 |
Why?
| Myofibroblasts | 1 | 2019 | 121 | 0.040 |
Why?
| Inhibitory Postsynaptic Potentials | 1 | 2018 | 40 | 0.040 |
Why?
| Mitosis | 1 | 1999 | 180 | 0.040 |
Why?
| Oligodendrocyte Precursor Cells | 1 | 2017 | 21 | 0.040 |
Why?
| Cell Line, Tumor | 1 | 2025 | 3185 | 0.030 |
Why?
| Coculture Techniques | 1 | 2018 | 224 | 0.030 |
Why?
| Trachea | 1 | 1999 | 231 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2019 | 334 | 0.030 |
Why?
| Strategic Planning | 1 | 2016 | 3 | 0.030 |
Why?
| Zinostatin | 1 | 2016 | 1 | 0.030 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2016 | 16 | 0.030 |
Why?
| Karyotyping | 1 | 2016 | 99 | 0.030 |
Why?
| Ethylnitrosourea | 1 | 2015 | 10 | 0.030 |
Why?
| Myosin Light Chains | 1 | 2015 | 27 | 0.030 |
Why?
| Diffusion | 1 | 2015 | 117 | 0.030 |
Why?
| Fluorescence Polarization | 1 | 2015 | 38 | 0.030 |
Why?
| Two-Hybrid System Techniques | 1 | 2015 | 55 | 0.030 |
Why?
| Anisotropy | 1 | 2015 | 73 | 0.030 |
Why?
| Base Sequence | 2 | 1996 | 2142 | 0.030 |
Why?
| Methylmercury Compounds | 1 | 2014 | 7 | 0.030 |
Why?
| NIH 3T3 Cells | 1 | 2015 | 140 | 0.030 |
Why?
| Troponin I | 1 | 2015 | 75 | 0.030 |
Why?
| Point Mutation | 1 | 1995 | 224 | 0.030 |
Why?
| Goals | 1 | 2016 | 163 | 0.030 |
Why?
| Genotype | 1 | 2019 | 1829 | 0.030 |
Why?
| Introns | 1 | 1995 | 249 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 371 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 329 | 0.030 |
Why?
| Axons | 1 | 2015 | 193 | 0.030 |
Why?
| Myocardial Contraction | 1 | 2015 | 335 | 0.030 |
Why?
| Protein Isoforms | 1 | 2015 | 393 | 0.030 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2014 | 199 | 0.030 |
Why?
| United States | 3 | 2021 | 13913 | 0.030 |
Why?
| Mice, Nude | 1 | 2015 | 680 | 0.030 |
Why?
| Genes, Lethal | 1 | 2013 | 29 | 0.030 |
Why?
| Terminology as Topic | 1 | 2014 | 204 | 0.030 |
Why?
| RNA, Ribosomal, 18S | 1 | 2013 | 23 | 0.030 |
Why?
| Manganese Compounds | 1 | 2012 | 2 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2015 | 426 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2020 | 2739 | 0.020 |
Why?
| Neurologic Examination | 1 | 2012 | 114 | 0.020 |
Why?
| HEK293 Cells | 1 | 2015 | 697 | 0.020 |
Why?
| PAX6 Transcription Factor | 1 | 2012 | 20 | 0.020 |
Why?
| Biomechanical Phenomena | 1 | 2015 | 766 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1847 | 0.020 |
Why?
| Homeostasis | 2 | 2007 | 605 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2014 | 310 | 0.020 |
Why?
| Age Factors | 1 | 1999 | 3161 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 1995 | 530 | 0.020 |
Why?
| Biosensing Techniques | 1 | 2012 | 118 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2015 | 2057 | 0.020 |
Why?
| Neural Inhibition | 1 | 2012 | 157 | 0.020 |
Why?
| Young Adult | 2 | 2018 | 12467 | 0.020 |
Why?
| Middle Aged | 3 | 2019 | 31177 | 0.020 |
Why?
| Pregnancy | 1 | 2023 | 6423 | 0.020 |
Why?
| Phosphorylation | 1 | 2014 | 1716 | 0.020 |
Why?
| Models, Molecular | 1 | 2015 | 1488 | 0.020 |
Why?
| Reactive Oxygen Species | 1 | 2012 | 592 | 0.020 |
Why?
| Risk Factors | 2 | 2014 | 9801 | 0.020 |
Why?
| Pilot Projects | 1 | 2014 | 1597 | 0.020 |
Why?
| Protein Binding | 1 | 2015 | 2123 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 5468 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 2016 | 0.020 |
Why?
| Infant, Newborn | 1 | 2019 | 5772 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 3089 | 0.020 |
Why?
| Nerve Degeneration | 1 | 2007 | 47 | 0.020 |
Why?
| T-Lymphocytes | 1 | 1995 | 1937 | 0.020 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2007 | 96 | 0.020 |
Why?
| Organ Culture Techniques | 1 | 2007 | 155 | 0.020 |
Why?
| Neocortex | 1 | 2007 | 32 | 0.020 |
Why?
| Long-Term Potentiation | 1 | 2007 | 192 | 0.010 |
Why?
| Treatment Outcome | 1 | 2018 | 10241 | 0.010 |
Why?
| Biological Transport, Active | 1 | 2003 | 78 | 0.010 |
Why?
| Gliosis | 1 | 2003 | 28 | 0.010 |
Why?
| Electrophysiology | 1 | 2003 | 213 | 0.010 |
Why?
| Hippocampus | 1 | 2007 | 844 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6550 | 0.010 |
Why?
| Immunoenzyme Techniques | 1 | 2002 | 211 | 0.010 |
Why?
| Retrospective Studies | 1 | 2018 | 14553 | 0.010 |
Why?
| Synapses | 1 | 2003 | 397 | 0.010 |
Why?
| Aged | 1 | 2016 | 22107 | 0.010 |
Why?
| Awards and Prizes | 1 | 1996 | 64 | 0.010 |
Why?
| Hematopoiesis | 1 | 1996 | 184 | 0.010 |
Why?
| Societies, Medical | 1 | 1996 | 759 | 0.010 |
Why?
| Biomarkers | 1 | 2002 | 3971 | 0.010 |
Why?
|
|
Ess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|